International Edu News: What will education look like in future  |  Leadership Instincts: Advanced Leadership Initiative welcomes its most diverse group of fellows  |  International Edu News: Diet may influence risk of aggressive prostate cancer  |  Teacher Insights: Laurie Anderson to present Norton Lectures  |  Policy Indications: NEP 2020: Implementation Plan for School Education  |  National Edu News: Union Education Minister virtually interacts with KV students   |  Expert Counsel: The India Way  |  Science Innovations: DST Scientists find clue to anomalous behaviour of self-propelled fluctuations  |  Technology Inceptions: INSPIRE Faculty fellow’s engineering to produce heat-tolerant wheat varieties  |  National Edu News: Indians to soon have access to Chitra Flow Diverter stent  |  National Edu News: Sensitive Youth will Create New India: Smriti Zubin Irani  |  Education Information: Sports Ministry to name all upgraded sporting facilities after sportspersons  |  Finance: Elephant in the Room  |  Guest Column: Pandemic Effect on Education  |  Parent Interventions: Fast food restaurant proximity likely doesn't affect children's weight   |  
November 30, 2020 Monday 11:16:24 AM IST

Government Launches Mission COVID Suraksha

National Edu News

The Government of India (GOI) has announced the third stimulus package of Rs. 900 Crore for the Mission COVID Suraksha- The Indian COVID-19 Vaccine Development Mission. This grant will be provided to the Department of Biotechnology (DBT) for Research & Development of Indian COVID-19 vaccines. The COVID-19 Vaccine development Mission with end-to-end focus from preclinical development through clinical development and manufacturing and regulatory facilitation for deployment, would consolidate all available and funded resources towards an accelerated product development. This will help accelerate development of approx. 5-6 vaccine candidates and ensure that these are brought closer to licensure and introduction in market for consideration of regulatory authorities for introduction in public health systems, to combat further spread of COVID infection.

The important objectives of the fund will be accelerating pre-clinical& clinical development; licensure of COVID-19 vaccine candidates that are currently in clinical stages or ready to enter clinical stage of development, establishing clinical trial sites, and strengthening the existing immunoassay laboratories, central laboratories and suitable facilities for animal studies, production facilities and other testing facilities to support COVID-19 vaccine development. The other important objective will be supporting development of common harmonized protocols, trainings, data management systems, regulatory submissions, internal and external quality management systems and accreditations.   Capabilities for process development, cell line development and manufacturing of GMP batches for animal toxicology studies and clinical trials will also be supported under the Mission. A key element will be development of suitable Target Product Profile so that vaccines being introduced through the mission have preferred characteristics applicable for India.

Led by Department of Biotechnology and implemented by a dedicated Mission Implementation Unit at Biotechnology Industry Research Assistance Council (BIRAC),the existing activities under National Bio Pharma Mission (NBM) and Ind-CEPI Mission will provide complementary strengths to this Mission. Phase-I of the COVID Suraksha Mission has been allotted Rs.900 Crore for a period of 12 months. A total of 10 vaccine candidates have been supported by Department of Biotechnology so far at both academia and industry and as on date, 5 vaccine candidates are in human trials including the Russian Vaccine Sputnik-V with at least 3 more in advanced stages of preclinical to enter human trials shortly.

Comments